Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP182078.RAN-52I00dLl2dISXKtxijNh9fNxbziUB0WUD9NCtcuVA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP182078.RAN-52I00dLl2dISXKtxijNh9fNxbziUB0WUD9NCtcuVA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP182078.RAN-52I00dLl2dISXKtxijNh9fNxbziUB0WUD9NCtcuVA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP182078.RAN-52I00dLl2dISXKtxijNh9fNxbziUB0WUD9NCtcuVA130_provenance.
- NP182078.RAN-52I00dLl2dISXKtxijNh9fNxbziUB0WUD9NCtcuVA130_assertion description "[Data suggest that SPRY2, an inhibitor of ERK signaling, may be bypassed in melanoma cells either by down-regulation of its expression in WT BRAF cells, or by the presence of the BRAF mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP182078.RAN-52I00dLl2dISXKtxijNh9fNxbziUB0WUD9NCtcuVA130_provenance.
- NP182078.RAN-52I00dLl2dISXKtxijNh9fNxbziUB0WUD9NCtcuVA130_assertion evidence source_evidence_literature NP182078.RAN-52I00dLl2dISXKtxijNh9fNxbziUB0WUD9NCtcuVA130_provenance.
- NP182078.RAN-52I00dLl2dISXKtxijNh9fNxbziUB0WUD9NCtcuVA130_assertion SIO_000772 15313890 NP182078.RAN-52I00dLl2dISXKtxijNh9fNxbziUB0WUD9NCtcuVA130_provenance.
- NP182078.RAN-52I00dLl2dISXKtxijNh9fNxbziUB0WUD9NCtcuVA130_assertion wasDerivedFrom lhgdn-20090331 NP182078.RAN-52I00dLl2dISXKtxijNh9fNxbziUB0WUD9NCtcuVA130_provenance.
- NP182078.RAN-52I00dLl2dISXKtxijNh9fNxbziUB0WUD9NCtcuVA130_assertion wasGeneratedBy ECO_0000203 NP182078.RAN-52I00dLl2dISXKtxijNh9fNxbziUB0WUD9NCtcuVA130_provenance.
- lhgdn-20090331 importedOn "2009-03-31" NP182078.RAN-52I00dLl2dISXKtxijNh9fNxbziUB0WUD9NCtcuVA130_provenance.